Cargando…

Polar Profile of Antiviral Peptides from AVPpred Database

Diseases of viral origin in humans are among the most serious threats to health and the global economy. As recent history has shown the virus has a high pandemic potential, among other reasons, due to its ability to spread by air, hence the identification, investigation, containment, and treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales: Polanco, Carlos, Samaniego, José Lino, Castañón-González, Jorge Alberto, Buhse, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091296/
https://www.ncbi.nlm.nih.gov/pubmed/24993579
http://dx.doi.org/10.1007/s12013-014-0084-4
_version_ 1783510003692339200
author Polanco, Carlos
Samaniego, José Lino
Castañón-González, Jorge Alberto
Buhse, Thomas
author_facet Polanco, Carlos
Samaniego, José Lino
Castañón-González, Jorge Alberto
Buhse, Thomas
author_sort Polanco, Carlos
collection PubMed
description Diseases of viral origin in humans are among the most serious threats to health and the global economy. As recent history has shown the virus has a high pandemic potential, among other reasons, due to its ability to spread by air, hence the identification, investigation, containment, and treatment of viral diseases should be considered of paramount importance. In this sense, the bioinformatics research has focused on finding fast and efficient algorithms that can identify highly toxic antiviral peptides and to serve as a first filter, so that trials in the laboratory are substantially reduced. The work presented here contributes to this effort through the use of an algorithm already published by this team, called polarity index method, which identifies with high efficiency antiviral peptides from the exhaustive analysis of the polar profile, using the linear sequence of the peptide. The test carried out included all peptides in APD2 Database and 60 antiviral peptides identified by Kumar and co-workers (Nucleic Acids Res 40:W199–204, 2012), to build its AVPpred algorithm. The validity of the method was focused on its discriminating capacity so we included the 15 sub-classifications of both Databases. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s12013-014-0084-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7091296
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-70912962020-03-24 Polar Profile of Antiviral Peptides from AVPpred Database Polanco, Carlos Samaniego, José Lino Castañón-González, Jorge Alberto Buhse, Thomas Cell Biochem Biophys Original Paper Diseases of viral origin in humans are among the most serious threats to health and the global economy. As recent history has shown the virus has a high pandemic potential, among other reasons, due to its ability to spread by air, hence the identification, investigation, containment, and treatment of viral diseases should be considered of paramount importance. In this sense, the bioinformatics research has focused on finding fast and efficient algorithms that can identify highly toxic antiviral peptides and to serve as a first filter, so that trials in the laboratory are substantially reduced. The work presented here contributes to this effort through the use of an algorithm already published by this team, called polarity index method, which identifies with high efficiency antiviral peptides from the exhaustive analysis of the polar profile, using the linear sequence of the peptide. The test carried out included all peptides in APD2 Database and 60 antiviral peptides identified by Kumar and co-workers (Nucleic Acids Res 40:W199–204, 2012), to build its AVPpred algorithm. The validity of the method was focused on its discriminating capacity so we included the 15 sub-classifications of both Databases. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s12013-014-0084-4) contains supplementary material, which is available to authorized users. Springer US 2014-07-04 2014 /pmc/articles/PMC7091296/ /pubmed/24993579 http://dx.doi.org/10.1007/s12013-014-0084-4 Text en © Springer Science+Business Media New York 2014 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Paper
Polanco, Carlos
Samaniego, José Lino
Castañón-González, Jorge Alberto
Buhse, Thomas
Polar Profile of Antiviral Peptides from AVPpred Database
title Polar Profile of Antiviral Peptides from AVPpred Database
title_full Polar Profile of Antiviral Peptides from AVPpred Database
title_fullStr Polar Profile of Antiviral Peptides from AVPpred Database
title_full_unstemmed Polar Profile of Antiviral Peptides from AVPpred Database
title_short Polar Profile of Antiviral Peptides from AVPpred Database
title_sort polar profile of antiviral peptides from avppred database
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091296/
https://www.ncbi.nlm.nih.gov/pubmed/24993579
http://dx.doi.org/10.1007/s12013-014-0084-4
work_keys_str_mv AT polancocarlos polarprofileofantiviralpeptidesfromavppreddatabase
AT samaniegojoselino polarprofileofantiviralpeptidesfromavppreddatabase
AT castanongonzalezjorgealberto polarprofileofantiviralpeptidesfromavppreddatabase
AT buhsethomas polarprofileofantiviralpeptidesfromavppreddatabase